Skip to main content
OpenTrials

Clinical trial condition

Triple Negative

Explore clinical trials studying Triple Negative. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Triple Negative trial results

Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

NCT04333706

Conditions
Breast, Cancer, Disseminated Tumor Cell, +7 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UF Health Gainesville, Florida, United States
View Trial Details

Related conditions